Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.89568 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.12084 | 94 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.01489 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 9.09177 | 96 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.44321 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.83641 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.89264 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.19842 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.35633 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.03393 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.73359 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.28685 | 94 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.63333 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.85542 | 93 |